Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.04%, DAX30 +0.21%, CAC40 +0.16%

Oct 24 ,2025

  • Synopsis

    • European equity futures indicate a firmer open following positive performance yesterday. STOXX Europe 600 on track for weekly gain. Asian equity markets mostly higher.

    • US equities were higher in Thursday trading. Stocks ended not far from off best levels,

    • White House confirmed President Trump to meet China's Xi at APEC summit on 30-Oct but meeting not expected to produce anything substantive beyond another truce dialing back recent tensions over rare earths and soybeans, and directives to continue negotiations on other matters.

    • In Central Banks today: Bundesbank's Nagel, Bank of France's Villeroy panellists at 14:45CET at Berlin Global Dialogue (Thu-Sat). ECB consumer inflation expectations will be released

    • On the macro data front, PMIs headline in Europe. Consensus is for modest improvement in manufacturing and services holding up. GfK UK consumer confidence edged in October ahead of UK retail sales release

    • Other macro data due: France Oct consumer confidence, Spain Sep PPI, Sweden Sep PPI, Finland Sep PPI

    • Out last night: UK Sep car manufacturing (27.1%) y/y to 51,090 units -- SMMT

    • Earnings reportes so far today: (SAN.FP) Sanofi reports Q3 Business EPS €2.91 vs consensus €2.70; confirms FY guidance. (NHY.NO) Norsk Hydro reports Q3 EPS NOK1.02 ex-items vs consensus NOK1.19. (LIGHT.NA) Signify reports Q3 EPS €0.60 vs consensus €0.53; now guides FY Comparable sales growth of (2.5%)-(3.0%). (HOFI.SS) Hoist Finance reports Q3 EPS SEK3.00 vs FactSet SEK2.74. (BONAV.B.SS) Bonava reports Q3 EPS (SEK0.36) vs FactSet SEK0.01. (KOMPL.NO) Komplett reports Q3 EPS (NOK0.24) vs FactSet (NOK0.16). (HOLN.SW) Holcim reports Q3 recurring EBIT CHF836M vs StreetAccount CHF815.2M. (SCHN.SW) Schindler Holding reports Q3 EPS CHF2.36 vs consensus CHF2.30

  • Politics/Macro/World News

    • Understanding the Latest US Sanctions on Russian Oil (BBG )

    • EU pledges financial aid to Ukraine but demurs on Russian assets plan (Reuters )

  • Top company news

    • Earnings/updates

      • KO (Coca-Cola) -- discloses it will be required to take a $1B charge in Q4 due to significant negative net foreign currency adjustments related to operations in Africa held for sale - 10-Q

      • HOLN.SW (Holcim) -- reports Q3 recurring EBIT CHF836M vs StreetAccount CHF815.2M; reaffirms FY guidance

      • AC.FP (Accor) -- reports Q3 revenue €1.43B vs consensus €1.38B

      • DG.FP (VINCI SA) -- reports Q3 revenue €19.40B vs StreetAccount €19.08B

      • SIKA.SW (Sika Group) -- reports 9M net income CHF870.9M vs StreetAccount CHF896M

      • FR.FP (Valeo SE) -- reports Q3 revenue €5.00B vs consensus €4.82B; confirms FY outlook

      • SCHN.SW (Schindler Holding) -- reports Q3 EPS CHF2.36 vs consensus CHF2.30

      • SFER.IM (Salvatore Ferragamo) -- reports 9M revenue €694.6M vs StreetAccount €682.3M

      • URW.FP (Unibail-Rodamco-Westfield) -- 9M trading update; guides Fy25 adj. AREPS at least €9.50 vs prior upper end of €9.30 to €9.50

      • ADP.FP (Aeroport de Paris) -- reports 9M revenue €5.04B, +9% vs year-ago €4.61B

      • BOL.FP (Bolloré) -- reports Q3 revenue €630M, (22%) vs year-ago €809M

      • HAG.GR (HENSOLDT) -- guides FY25 revenue ~€2.5B vs prior €2.50-2.60B and FactSet €2.55B

      • SK.FP (SEB) -- reports preliminary Q3 revenue €1.92B vs FactSet €1.95B [1 est]

      • ATE.FP (Alten) -- reports Q3 revenue €3.08B vs year-ago €3.12B; confirms FY outlook

      • VIS.SM (Viscofan) -- reports Q3 net income €38.9M vs FactSet €37.2M [6 est, €34-40M]

      • FII.FP (Lisi) -- reports Q3 revenue €464.4M vs FactSet €455.4M [2 est, €450.9-459.9M]

      • MDM.FP (Maisons du Monde) -- reports Q3 revenue €224.7M, +5% vs year-ago €214.1M

      • YUBICO.SS (Yubico) -- reports preliminary Q3 revenue SEK548M vs FactSet SEK571.3M [4 est, SEK555-581M]

      • NXI.FP (Nexity) -- CORRECTION: Nexity reports Q3 revenue €632M, (25%) vs year-ago €848M

      • NXI.FP (Nexity) -- reports Q3 revenue €632M, (25%) vs year-ago €848M

      • TKO.FP (Tikehau Capital) -- reports Q3 AuM €51.1B as of 30-Sep-25, +9% y/y

      • GBT.FP (Guerbet) -- reports Q3 revenue €198.7M vs FactSet €199.3M [1 est]

      • ALCGM.FP (Cegedim) -- reports preliminary Q3 revenue €153.7M vs year-ago €156.8M

      • MRN.FP (Mersen) -- reports Q3 revenue €284.5M vs FactSet €306.6M [1 est]

      • LIN.FP (Linedata Services) -- reports Q3 revenue €122.0M, (9%) vs year-ago €134.6M; anticipates 5% to 10% decrease in revenue for the the full year

    • M&A

      • IBE.SM (Iberdrola) -- Fortescue emerging as leading candidate to acquire 49% stake in Spanish solar power portfolio owned by Iberdrola - Bloomberg (23-Oct, 16:30 CET/24-Oct, 1:30 AEDT)

      • KO (Coca-Cola) -- discloses it will be required to take a $1B charge in Q4 due to significant negative net foreign currency adjustments related to operations in Africa held for sale - 10-Q

      • URW.FP (Unibail-Rodamco-Westfield) -- Follow-up: Unibail-Rodamco-Westfield acquires 25% stake in St James Quarter in Edinburgh

      • FII.FP (Lisi) -- announces agreement with SK CAPITAL for sale of MEDICAL division

      • PFD.LN (Premier Foods) -- looking at acquisition opportunities in Australia - The Australian

      • PKTM.SW (PIERER Mobility) -- Austrian Takeover Commission confirms restructuring privilege for acquisition of control by Bajaj Auto acquisition of control of Pierer Mobility

      • SPEC.LN (Inspecs Group) -- issues statement regarding possible offer

      • SWP.FP (Sword Group) -- reports Q3 EBITDA €11.0M vs year-ago €9.8M

      • SWP.FP (Sword Group) -- discloses acquisition of Spanish technology consulting firm, Full On Net; terms not disclosed

      • AEIN.GR (Allgeier) -- sells subsidiary IT Services to Synova, terms undisclosed

      • Advent International and TA Associates reportedly in early stages to sell Conservice for $4.5-$5B valuation - Reuters

      • SS&C Technologies and Bravura Solutions register interest Grow Inc sale with bids of A$250M (~$163M) sought - Australian Financial Review

    • Healthcare

      • GSK.LN (GSK Plc) -- FDA approves GSK Plc BLENREP in combination with other treatments for patients for treating relapsed or refractory multiple myeloma - Reuters

      • GSK.LN (GSK Plc) -- issues press release on FDA approval of Blenrep, new REMS

      • GLPG.NA (Galapagos) -- to present In Vitro Data at ACR Convergence 2025 on GLPG3667 vs other TYK2 Inhibitors

      • HLUN.B.DC (H. Lundbeck) -- Follow-up: FDA approves efficacy supplment for Vyepti

      • EGTX.SS (Egetis Therapeutics) -- Transcript Intelligence: Egetis Therapeutics Business Update Call

    • Other

      • SAP.GR (SAP) -- Street Takeaways - SAP Q3 Earnings

      • NOKIA.FH (Nokia) -- extends long-term partnership with VNPT in Vietnam

      • UBSG.SW (UBS Group) -- announces management changes: appoints new Group Head Compliance and Operational Risk Control, COO and CTO effective 1-Jan

      • SU.FP (Schneider Electric) -- launches consulting practice to support clients in solving sustainability, energy, and technology challenges

      • URW.FP (Unibail-Rodamco-Westfield) -- names Vincent Rouget CEO effective 1-Jan-26

      • DEC.FP (JCDecaux) -- announces advertising contract with Bane NOR

      • Canada to limit the number of tariff-free vehicles Stellantis and GM can import from US to sell in Canada - CBC

      • UK Sep car manufacturing (27.1%) y/y to 51,090 units -- SMMT (00:01ET)

  • Key rating changes

    • Upgrades

      • IVSO.SS (INVISIO) -- to buy from hold at DNB Carnegie

      • IVSO.SS (INVISIO) -- to hold from sell at Pareto (earlier, timing uncertain)

      • KCR.FH (Konecranes) -- to buy from hold at DNB Carnegie

      • KGF.LN (Kingfisher) -- to outperform from sector perform at RBC Capital Markets

      • METSO.FH (Metso Corp.) -- to hold from sell at ABG Sundal Collier

      • SMWH.LN (WH Smith) -- to buy from hold at Peel Hunt

      • TELIA.SS (Telia Co.) -- to buy from hold at DNB Carnegie

      • VOLCAR.B.SS (Volvo Car) -- to buy from hold at DNB Carnegie

    • Downgrades

      • EVO.SS (Evolution) -- to hold from buy at Pareto

      • SW.FP (Sodexo) -- to hold from buy at Kepler Cheuvreux

      • BAVA.DC (Bavarian Nordic A/S) -- to hold from buy at DNB Carnegie

      • ELISA.FH (Elisa Oyj) -- to hold from buy at DNB Carnegie

    • Initiations

      • EDV.LN (Endeavour Mining) -- overweight at JPMorgan

      • DOKA.SW (dormakaba Holding) -- buy at Deutsche Bank

  • Data

    • Nikkei +1.33% to 49288.28

    • Hang Seng +0.44% to 26082.96

    • Shanghai Composite +0.49% to 3941.74

    • S&P futures +15.0 vs prior close of 6775.0

    • €-$ (0.0012) or (0.10%) to 1.1606

    • $-¥ +0.31 or +0.20% to 152.90 €-¥ +0.19 or +0.11% to 177.46

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE